Finance

Lists
OBIO:NASDAQ
Orchestra Biomed Holdings Inc
$ 5.91
-0.67%
(-0.040) 1D
$ 5.91
0.00% (0.00)
After hours
Closed: 10-р сарын 12, 16:00:00 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OBIO...
Open
$ 5.93
High
$ 5.99
Low
$ 5.39
Mkt. cap
355.22 сая
Avg. vol.
339.23 мян
Volume
237.98 мян
52-wk high
$ 6.50
52-wk low
$ 3.06
EPS
-$ 1.01
Beta
0.52
Shares outstanding
60.10 сая
No. of employees
86
Open
$ 5.93
High
$ 5.99
Low
$ 5.39
Mkt. cap
355.22 сая
Avg. vol.
339.23 мян
Volume
237.98 мян
52-wk high
$ 6.50
52-wk low
$ 3.06
EPS
-$ 1.01
Beta
0.52
Shares outstanding
60.10 сая
No. of employees
86
News stories
From web sources and news partners
About Orchestra Biomed Holdings Inc
CEO-
Employees86
Founded2018
Headquarters-
Sector-
Websiteorchestrabiomed.com
Analyst ratings
Based on 5 analysts giving stock ratings to OBIO in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for OBIO in the last 3 months.
Highest
Current $ 5.91
$ 15.00 (+153.81%)
Average
$ 11.20 (+89.51%)
Lowest
$ 10.00 (+69.20%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yi Chen
H.C. Wainwright
Buy
Reiterated
$ 10.00
+69.2%
10/05/2026
Madison Elsaadi
B. Riley Securities
Buy
Reiterated
$ 11.00
+86.1%
10/02/2026
Josh Jennings
TD Cowen
Buy
Reiterated
$ 15.00
+153.8%
09/25/2026
Marie Thibault
BTIG
Buy
Upgraded
$ 10.00
+69.2%
09/10/2026
Matthew O'Brien
Piper Sandler
Buy
Reiterated
$ 10.00
+69.2%
08/11/2026
Unknown Analyst
BTIG
Hold
Maintained
-
-
07/09/2026
Anderson Schock
B. Riley Securities
Buy
Reiterated
$ 10.00
+69.2%
05/18/2026
Matt Miksic
Barclays
Buy
Reiterated
$ 13.00
+120%
05/13/2026
Keay Nakae
Chardan Capital
Buy
Maintained
$ 20.00
+238.4%
03/12/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
861.00 мян
30.92 сая
110.00 мян
88.00 мян
Cost of goods sold
49.00 мян
51.00 мян
32.00 мян
25.00 мян
Cost of revenue
49.00 мян
51.00 мян
32.00 мян
25.00 мян
Research and development expenses
14.03 сая
16.82 сая
15.78 сая
16.59 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.10 сая
7.29 сая
6.37 сая
5.83 сая
Operating expense
21.12 сая
24.11 сая
22.15 сая
22.42 сая
Total operating expenses
21.17 сая
24.16 сая
22.19 сая
22.44 сая
Operating income
-20.31 сая
6.75 сая
-22.08 сая
-22.36 сая
Other non operating income
-
254.00 мян
-376.00 мян
-517.00 мян
EBT including unusual items
-20.83 сая
6.24 сая
-20.69 сая
-23.76 сая
EBT excluding unusual items
-20.83 сая
6.24 сая
-22.93 сая
-23.80 сая
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-20.83 сая
6.24 сая
-20.69 сая
-23.76 сая
Net profit margin
-2,419.05%
20.20%
-18,810.00%
-26,994.32%
Earnings per share
-0.40
0.26
-0.33
-0.37
Interest and investment income
-
752.00 мян
-
-
Interest expense
-515.00 мян
-1.52 сая
-480.00 мян
-927.00 мян
Net interest expenses
-515.00 мян
-763.00 мян
-480.00 мян
-927.00 мян
Depreciation and amortization charges
-
-
-
-
EBITDA
-20.23 сая
6.84 сая
-21.99 сая
-22.26 сая
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google аппс